Skip to main content
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.915
-0.085 (-4.25%)
Dec 3, 2024, 2:02 PM EST - Market open

Milestone Pharmaceuticals Revenue

In the year 2023, Milestone Pharmaceuticals had annual revenue of $1.00M, down -80.00%.

Revenue (ttm)
$1.00M
Revenue Growth
-80.00%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
47
Market Cap
126.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.00M-4.00M-80.00%
Dec 31, 20225.00M-10.00M-66.67%
Dec 31, 202115.00M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 942.61M
Protalix BioTherapeutics 45.67M
Vaxart 16.76M
Lineage Cell Therapeutics 8.72M
Akso Health Group 2.41M
Cardiff Oncology 688.00K
Revenue Rankings

MIST News

More News